faropenem + clavulanate

Faropenem + clavulanate (also known as faropenem/clavulanate) is an oral antibacterial combination drug that pairs faropenem, a penem-class beta-lactam antibiotic, with clavulanate (clavulanic acid), a beta-lactamase inhibitor. Faropenem works by binding to penicillin-binding proteins (PBPs) to inhibit bacterial cell wall synthesis, leading to cell lysis and death. Clavulanate acts as a suicide inhibitor of beta-lactamase enzymes, preventing them from degrading faropenem and thereby restoring and extending its antibacterial spectrum against resistant, beta-lactamase-producing pathogens. This combination is approved and marketed in India for treating various moderate-to-severe bacterial infections, including respiratory tract infections (such as pneumonia, bronchitis, and sinusitis), urinary tract infections, skin and soft tissue infections, gynecological infections, and dental infections.

Brand names

Depenem CVFaroPair CVFaroalfa CVFarochem-CV 325Farochem-CV325Farochem-CV-325FARODEN-CVFarofence CVFaroline-CVFaromik CVFAROMITS CVFaronem CVFAROPINOM DUOFaropare cvFarovil CVFazrix CVFcvergeFerocan-CVFerofic CVForth CVINTRAPAM-CVPlerocin CV

Other names

faropenem + clavulanic acidfaropenem and clavulanatefaropenem and clavulanic acidfaropenem sodium + potassium clavulanatefaropenem sodium and potassium clavulanatefaropenem/clavulanatefaropenem/clavulanic acid